The S&P/ASX 200 has added more than 2% over the five-day trading week despite taking minor hits over the past two days.
The Iran war has turned the gold market on its head, but experts say the long-term outlook is getting even better.
1414 Degrees has firm commitments to raise $2.69 million in a placement to sophisticated, professional and institutional investors.
Stockhead’s end-of-week wrap covering small-cap ASX movers, news of note and expert recommendations.
The ASX healthcare sector up 2.66% for week ending March 27, 2026 as Lumos Diagnostics received a US CLIA-waiver in the US for FebriDx.
Lumos completes US$14 million ($20m) placement to institutional investors to support US rollout of FebriDX
